文献速递泌尿生殖腹部MR

炎症性肠病患者的前列腺MRI特征

Prostate MRI characteristics in patients with inflammatory bowel disease.
PubMed 文献 · Eur J Radiol · 2021-01-05

本研究评估了3140例接受前列腺MRI检查的患者,其中71例合并炎症性肠病(IBD)。IBD组异常MRI比例与无IBD组无显著差异,但IBD组病理证实的临床显著前列腺癌比例及异常MRI对临床显著前列腺癌的阳性预测值均显著低于无IBD组。

要点

  • IBD组异常MRI(PI-RADS 3、4或5)比例为51%(36/71),无IBD组为47%(1436/3069),差异无统计学意义(p=0.513)。
  • IBD组病理证实的临床显著前列腺癌比例为35%(12/34),无IBD组为56%(699/1251),差异有统计学意义(p=0.017)。
  • IBD组异常MRI对临床显著前列腺癌的阳性预测值为39%(19/31),无IBD组为63%(657/1047),差异有统计学意义(p=0.007)。

诊断标准与关键数值

  • 临床显著前列腺癌定义为Gleason评分7分及以上,非临床显著前列腺癌定义为良性或Gleason评分6分。
  • 异常MRI定义为PI-RADS 3、4或5分。
  • IBD组异常MRI比例为51%(36/71),无IBD组为47%(1436/3069),p=0.513。
  • IBD组病理证实的临床显著前列腺癌比例为35%(12/34),无IBD组为56%(699/1251),p=0.017。
  • IBD组异常MRI对临床显著前列腺癌的阳性预测值为39%(19/31),无IBD组为63%(657/1047),p=0.007。

临床应用与阅片要点

  • 在IBD患者中,异常MRI对临床显著前列腺癌的阳性预测值低于无IBD患者,阅片和报告时需结合这一背景解读PI-RADS 3、4或5分病变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Previous studies have indicated an increased risk of prostate carcinoma (PCa) associated with inflammatory bowel disease (IBD). Prostate MRI of IBD patients could be expected to show a mixture of inflammation as well as higher than normal rates of PCa, which could impact interpretation and MRI performance. The purpose of this study is to evaluate the characteristics of prostate MRI in patients with IBD.

METHODS: 3140 patients with prostate MRI were evaluated. Coexisting IBD, PI-RADS score, and pathological results of prostate lesions (clinically significant PCa [csPCa]: Gleason score [GS] 7+, Non-csPCa: benign or GS 6) were assessed. The distribution of PI-RADS scoring and pathological result was assessed by chi-square test.

RESULTS: 71 patients had IBD (IBD group), whereas the remaining 3069 patients did not (Non-IBD group). The proportion of abnormal MRI (PI-RADS 3, 4 or 5) was 51 % (36/71) in IBD group and 47 % (1436/3069) in Non-IBD groups (p = 0.513). Total of 1285 patients underwent biopsy or prostatectomy. The proportion of csPCa at pathology was 35 % (12/34) in IBD group and 56 % (699/1251) in non-IBD groups (p = 0.017). The positive predictive value of abnormal MRI for csPCa was significantly lower in IBD group (39 %, 19/31) compared to Non-IBD group (63 %, 657/1047) (p = 0.007).

CONCLUSION: The proportion of csPCa at pathology and positive predictive value of abnormal MR for csPCa were lower in patients with IBD group compared to Non-IBD group.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Takahashi H, Froemming AT, Bruining DH, et al. Prostate MRI characteristics in patients with inflammatory bowel disease. Eur J Radiol. 2021. PMID: 33418382. doi:10.1016/j.ejrad.2020.109503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。